Global health regulators have sounded the alarm on the extremely popular heartburn drug Zantac (Ranitidine), which has prompted a flood of calls to our law firm concerning the filing of Zantac lawsuits. Zantac is also used to treat erosive esophagitis, Zollinger Ellison syndrome and more. The blockbuster drug and its generic versions have been found to contain the cancer-causing drug nitrosamine impurity called N-nitrosodimethylamine (NDMA).
The U.S. Food & Drug Administration (FDA) and drug-safety officials in Europe have identified that NDMA has been found in Zantac.
“Patients should be able to trust that their medicines are as safe as they can be and that the benefits of taking them outweigh any risk to their health.”
Table of Contents
- Zantac and Cancer
- How was NDMA discovered in Zantac?
- Zantac Recall
- Zantac May Contain 3,000% The Limit of NDMA Set by Regulators
- Do I Have a Zantac Lawsuit?
Zantac and Cancer
Does Zantac cause cancer? NDMA has been shown to cause cancer. Since NDMA has been found in Zantac and Ranitidine, it is safe to assume that Zantac may cause cancer.
NDMA has been linked to a number of life-threatening cancers including the following:
- Liver cancer
- Kidney cancer
- Intestinal cancer
- Stomach cancer
- Pancreatic cancer
- Colon cancer
- Lung cancer
- Ovarian cancer
- Esophageal cancer
- Testicular Cancer
How was NDMA discovered in Zantac?
The discovery was first published by Bloomberg and brought to the attention of the FDA by Valisure, a pharmacy in New Haven, Connecticut. Valisure tests all of the medications that it dispences and found that NDMA was in both Zantac and its generic versions.
Has Zantac been recalled? Sanofi issued a recall for Zantac OTC in the U.S. and Canada over potential NDMA contamination on October 18, 2019.
Generic Zantac Recall Update: Apotex Corp. Recalls Generic Zantac (Ranitidine) Sold At Walgreens, Walmart, and Rite-Aid – The recall affects both brand and generic formulations of 75 and 150 mg ranitidine tablets produced by a variety of manufacturers. The affected heartburn medications contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA). Most of the products are simply labeled as “Ranitidine Tablets” but the ones sold at Walgreens are branded as Wal-Zan®.
Sandoz Inc. has announced a Nationwide recall of Ranitidine Hydrochloride Capsules, which is prescribed for the treatment of duodenal ulcer, benign gastric ulcer, reflux esophagitis, post-operative peptic ulcer, Zollinger-Ellison Syndrome, and other conditions.
Zantac May Contain 3,000% The Limit of NDMA Set by Regulators
Starting in 2018, our lawyers started representing cancer victims exposed to NDMA through blood pressure medications like Valstartan and Losartan. These drugs contained approximately 17 micrograms of NDMA and were causing various cancers.
In the aftermath of the recalls on NDMA containing blood-pressure medications, the FDA set an NDMA limit of less than one microgram for those drugs and any others.
Regarding Zantac and Ranitidine, the FDA said the NDMA levels in the drugs are low, while Valisure’s Zantac recall petition called them “excessive.”
In fact, Valisure found that Zantac and many of its generics contained NDMA levels as high as 3,000 micrograms.
Is Zantac safe? With levels of cancer-causing NDMA in Zantac exceeding the FDA approved limit by 3,000 micrograms, Zantac or Ranitidine may not be safe.
To learn more about NDMA, please visit the Agency for Toxic Substances and Disease Registry.
Do I Have a Zantac Class Action Lawsuit? Talk with a Class Action Lawyer.
The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zantac lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.
Again, If you or somebody you know has taken Zantac or its generic versions and subsequently been diagnosed with cancer, you may be entitled to financial compensation by filing a Zantac cancer lawsuit.
Our lawyers offer a free review of your potential case. Please use the form below to contact us today.